The medicine "Inverin 90" is a relatively new development of Russian scientists. The drug has a pronounced antiviral effect. The tool "Inoverin" is active against influenza virus (A / H1N1 and its other modifications), influenza B, parainfluenza, adenovirus, as well as respiratory syncytial infection.
The active component of the drug is pentanedioic acid imidazolylethanamide.
The drug "Inverin 90" instruction allows for use for the treatment of influenza B and A and other acute respiratory infections of a viral nature.
The medication is available in red (or blue) capsules containing powder and granules of white with a creamy or pure white color.
Describing the medicine "Inoverin", the instructions for use indicate the presence of immunomodulating activity based on an increase in the production of interferon by leukocytes and, as a result, an increase in its (interferon) concentration in plasma. The medicine promotes the formation of T-killers (cells that kill the virus). The drug "Inoverin" (instructions for use indicates this) helps accelerate the functional maturation of neutrophils.
The anti-inflammatory effect of the drug is associated with a suppression of the production of key cytoxins, a decrease in the activity of myeloperixidase. With influenza, the therapeutic effect is manifested by shortening the febrile period, reducing intoxication, alleviating headache, dizziness, eliminating weakness, catarrhal phenomena, as well as reducing the number of complications and the duration of the disease.
In the course of the research it was found that the medicine "Inoverin" does not have a carcinogenic or mutagenic effect, does not affect the state of reproductive function. The drug is not able to provide immunotoxic and allergenic effects, does not have locally irritating properties.
When ingested, a uniform distribution of the active component over organs and tissues is noted. After thirty minutes after administration, the maximum concentration of the drug in the blood is observed. Withdrawal of the drug is unchanged.
Means "Inverin" instructions for use recommends to be taken orally, regardless of food.
The medicine should be taken from the moment the first signs of the disease appear, not later than thirty-six hours from its onset.
The drug is usually prescribed ninety milligrams once a day. Depending on the severity of the condition, the duration of treatment can be from five to seven days.
Among the side effects when taking the medicine "Inoverin", the instructions for use call allergic reactions. As practice shows, these effects are noted in rare cases.
Do not prescribe medication to patients under the age of eighteen years, and also with individual intolerance to the components.
Due to the fact that the use of the drug by pregnant and lactating women has not been studied, it is not recommended to prescribe the drug "Inoverin" in this category of patients. If necessary, take the drug during feeding, lactation is stopped.
Medication "Inverin" does not have an effect on the speed of psychomotor reactions, concentration of attention and visual acuity. In this regard, restrictions on the use of the drug to persons whose activities are considered to be potentially dangerous have not been established.
Cases of overdose with the drug "Inoverin" are not described.
Other drug interactions
The ability of the drug "Inoverin" to enhance the antitumor activity of cytostatics, to reduce the toxic effect of the drug "Cyclophosphamide".
Despite the fact that the reviews about the medicine from both specialists and patients are in most cases positive, the medication should be agreed with the doctor.